761 related articles for article (PubMed ID: 30359560)
21. Chemical transformation mediated CRISPR/Cas9 genome editing in Escherichia coli.
Sun D; Wang L; Mao X; Fei M; Chen Y; Shen M; Qiu J
Biotechnol Lett; 2019 Feb; 41(2):293-303. PubMed ID: 30547274
[TBL] [Abstract][Full Text] [Related]
22. High-efficiency non-mosaic CRISPR-mediated knock-in and indel mutation in F0
Aslan Y; Tadjuidje E; Zorn AM; Cha SW
Development; 2017 Aug; 144(15):2852-2858. PubMed ID: 28694259
[TBL] [Abstract][Full Text] [Related]
23. Using Microinjection to Generate Genetically Modified Caenorhabditis elegans by CRISPR/Cas9 Editing.
Iyer J; DeVaul N; Hansen T; Nebenfuehr B
Methods Mol Biol; 2019; 1874():431-457. PubMed ID: 30353529
[TBL] [Abstract][Full Text] [Related]
24. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
26. CRISPR-Cas9 technology and its application in haematological disorders.
Zhang H; McCarty N
Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
[TBL] [Abstract][Full Text] [Related]
27. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
28. Mosaicism diminishes the value of pre-implantation embryo biopsies for detecting CRISPR/Cas9 induced mutations in sheep.
Vilarino M; Suchy FP; Rashid ST; Lindsay H; Reyes J; McNabb BR; van der Meulen T; Huising MO; Nakauchi H; Ross PJ
Transgenic Res; 2018 Dec; 27(6):525-537. PubMed ID: 30284144
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas9-mediated efficient genome editing via protoplast-based transformation in yeast-like fungus Aureobasidium pullulans.
Zhang Y; Feng J; Wang P; Xia J; Li X; Zou X
Gene; 2019 Aug; 709():8-16. PubMed ID: 31132514
[TBL] [Abstract][Full Text] [Related]
30. Simple Protocol for Generating and Genotyping Genome-Edited Mice With CRISPR-Cas9 Reagents.
Fernández A; Morín M; Muñoz-Santos D; Josa S; Montero A; Rubio-Fernández M; Cantero M; Fernández J; Del Hierro MJ; Castrillo M; Moreno-Pelayo MÁ; Montoliu L
Curr Protoc Mouse Biol; 2020 Mar; 10(1):e69. PubMed ID: 32159922
[TBL] [Abstract][Full Text] [Related]
31. Developmental competence of porcine genome-edited zygotes.
Gil MA; Martinez CA; Nohalez A; Parrilla I; Roca J; Wu J; Ross PJ; Cuello C; Izpisua JC; Martinez EA
Mol Reprod Dev; 2017 Sep; 84(9):814-821. PubMed ID: 28471514
[TBL] [Abstract][Full Text] [Related]
32. An efficient DNA- and selectable-marker-free genome-editing system using zygotes in rice.
Toda E; Koiso N; Takebayashi A; Ichikawa M; Kiba T; Osakabe K; Osakabe Y; Sakakibara H; Kato N; Okamoto T
Nat Plants; 2019 Apr; 5(4):363-368. PubMed ID: 30911123
[TBL] [Abstract][Full Text] [Related]
33. Production of non-mosaic genome edited porcine embryos by injection of CRISPR/Cas9 into germinal vesicle oocytes.
Su X; Chen W; Cai Q; Liang P; Chen Y; Cong P; Huang J
J Genet Genomics; 2019 Jul; 46(7):335-342. PubMed ID: 31378649
[TBL] [Abstract][Full Text] [Related]
34. Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Liu C; Zhang L; Liu H; Cheng K
J Control Release; 2017 Nov; 266():17-26. PubMed ID: 28911805
[TBL] [Abstract][Full Text] [Related]
35. The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review.
Musunuru K
JAMA Cardiol; 2017 Aug; 2(8):914-919. PubMed ID: 28614576
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9: a breakthrough in generating mouse models for endocrinologists.
Markossian S; Flamant F
J Mol Endocrinol; 2016 Aug; 57(2):R81-92. PubMed ID: 27272521
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas9-mediated gene editing in human MPS I fibroblasts.
de Carvalho TG; Schuh R; Pasqualim G; Pellenz FM; Filippi-Chiela EC; Giugliani R; Baldo G; Matte U
Gene; 2018 Dec; 678():33-37. PubMed ID: 30081189
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9-mediated MSTN disruption and heritable mutagenesis in goats causes increased body mass.
Wang X; Niu Y; Zhou J; Zhu H; Ma B; Yu H; Yan H; Hua J; Huang X; Qu L; Chen Y
Anim Genet; 2018 Feb; 49(1):43-51. PubMed ID: 29446146
[TBL] [Abstract][Full Text] [Related]
39. Generation of albino medaka (Oryzias latipes) by CRISPR/Cas9.
Fang J; Chen T; Pan Q; Wang Q
J Exp Zool B Mol Dev Evol; 2018 Jun; 330(4):242-246. PubMed ID: 29873175
[TBL] [Abstract][Full Text] [Related]
40. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
